Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
99189-60-3NC(=O)CC1(CC(=O)O)CCCCC1QJGSJXLCJRXTRY-UHFFFAOYSA-N99189-60-3DTXSID70349837CHEMBL1342567Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 75% (3 of 4) of all reports.
Warning
H315 (25%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (25%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (25%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 3 of 4 reports by companies.;There is 1 notification provided by 1 of 4 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Status: Active Update: 25-02-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/4682;Status: Active Update: 15-10-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/1514;Status: Active Update: 26-02-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/4730;Status: Active Update: 11-03-2011 https://echa.europa.eu/registration-dossier/-/registered-dossier/9826
Status: Active Update: 01-12-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/4661
Verwenden1,1-Cyclohexanediacetic acid monoamide is an impurity of Gabapentin (G117250), an amino acid structurally related to γ-Aminobutyric Acid (GABA), designed to cross the blood brain barrier.Gabapentin is used as an anticonvulsant.
Wird geladen…
Status: Active Update: 25-02-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/4682;Status: Active Update: 15-10-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/1514;Status: Active Update: 26-02-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/4730;Status: Active Update: 11-03-2011 https://echa.europa.eu/registration-dossier/-/registered-dossier/9826
Status: Active Update: 01-12-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/4661